Purpose: To compare the intraocular pressure (IOP)-lowering efficacy of topically administered bimatoprost 0.03% with la-tanoprost 0.005% in patients with ocular hypertension (OHT) or glaucoma. Design: Multicenter, in...Purpose: To compare the intraocular pressure (IOP)-lowering efficacy of topically administered bimatoprost 0.03% with la-tanoprost 0.005% in patients with ocular hypertension (OHT) or glaucoma. Design: Multicenter, investigator-masked, 6-month randomized clinical trial. Methods: After washout of glaucoma medications, patients with OHT or glaucoma were randomly as-展开更多
文摘Purpose: To compare the intraocular pressure (IOP)-lowering efficacy of topically administered bimatoprost 0.03% with la-tanoprost 0.005% in patients with ocular hypertension (OHT) or glaucoma. Design: Multicenter, investigator-masked, 6-month randomized clinical trial. Methods: After washout of glaucoma medications, patients with OHT or glaucoma were randomly as-
